According to the CDC’s 2012 NHANES study, axial spondyloarthritis (axSpA) – an inflammatory rheumatic disease – affects roughly 3.2 million adults in the U.S. alone, making it more common than rheumatoid arthritis. Despite this reality, axSpA is not always well understood by the general public or even medical professionals.
AxSpA is often difficult to diagnose partly because its most common symptom, back pain, is a pervasive patient complaint. This partially explains why it can take up to 10 years to obtain the correct diagnosis. One helpful clue, however is the presence of inflammatory back pain.
Take our free online course to increase your knowledge and awareness of axial spondyloarthritis (axSpA) and learn the tools to appropriately suspect, diagnose, and refer axSpA patients to rheumatology, with the ultimate goal of improving patient outcomes.
Learn more by taking our FREE online educational course for Primary Care Providers
Demystifying Axial Spondyloarthritis in Primary Care: Recognition, Diagnosis, and What Comes Next
If are having trouble viewing the course: Click Here
Get information about inflammatory back pain, one of the most widespread symptoms of spondyloarthritis.
Get information about inflammatory back pain, one of the most widespread symptoms of spondyloarthritis.
Get information about inflammatory back pain, one of the most widespread symptoms of spondyloarthritis.
Here are three different criteria that can help determine if your patient may have IBP:
IBP if 4 / 5 are present.
IBP if 2 / 4 are present.
IBP if 4 / 5 are present.
Most cases of spondyloarthritis can be diagnosed or, at least, initially suspected, based on medical history and clinical examination.
Inflammation of the entheses, where joint capsules, ligaments, or tendons attach to bone. This can be felt in multiple areas of the body from shoulders down to the feet.
Inflammation of an entire digit (a finger or toe.)
Inflammation of the eye. Symptoms often occur in one eye at a time, and they may include redness, pain, sensitivity to light, and skewed vision.
Bloodwork may not always be helpful in screening for SpA, as many of the usual inflammatory markers are missing. SpA is seronegative (a negative blood test result), and has no association with rheumatoid factor or antinuclear antibodies. The presence of the HLA-B27 gene marker, however, can be a very helpful clue, though not everyone with SpA will test positive for this marker.
Also, common indicators of systemic inflammation, such as an elevated erythrocyte sedimentation rate (ESR/SED rate) and elevated C-reactive protein (CRP) are not always present in SpA patients.
Input your search keywords and press Enter.